Literature DB >> 26318171

Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis.

Melissa Krystel-Whittemore1, Ellen T McCarthy2, Ivan Damjanov1, Timothy A Fields1.   

Abstract

Polyomavirus nephropathy is commonly seen in the renal allograft setting but is uncommon in native kidneys. This paper describes polyomavirus nephropathy that developed in the native kidneys of a patient following immunosuppressive therapy for rheumatoid arthritis/Sjögren's syndrome associated lung disease. The patient presented with dyspnoea and a slow steady rise in serum creatinine. Owing to chronic immunosuppression, calcineurin-inhibitor toxicity was suspected. However, renal biopsy revealed polyomavirus nephropathy. The treatment of choice, lowered immunosuppression, was complicated by exacerbation of the patient's lung disease. This case highlights features of polyomavirus nephropathy in the native kidney, as well as the difficulty in its treatment when immunosuppressive treatment is necessary for medical comorbidities. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26318171      PMCID: PMC4693117          DOI: 10.1136/bcr-2015-211564

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  33 in total

1.  Differential diagnosis between infection and rejection in renal allografts.

Authors:  R B Colvin; S Mauiyyedi
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance.

Authors:  H Dheir; S Sahin; M Uyar; A Gurkan; V Turunc; S Kacar; D Bayirli Turan; G Basdemir
Journal:  Transplant Proc       Date:  2011-04       Impact factor: 1.066

Review 3.  Management of polyomavirus-associated nephropathy in renal transplant recipients.

Authors:  Dirk R J Kuypers
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

4.  Efficacy of levofloxacin in the treatment of BK viremia: a multicenter, double-blinded, randomized, placebo-controlled trial.

Authors:  Belinda T Lee; Steven Gabardi; Monica Grafals; R Michael Hofmann; Enver Akalin; Aws Aljanabi; Didier A Mandelbrot; Deborah B Adey; Eliot Heher; Pang-Yen Fan; Sarah Conte; Christine Dyer-Ward; Anil Chandraker
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 8.237

5.  Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.

Authors:  Genovefa A Papanicolaou; Yeon Joo Lee; James W Young; Surya V Seshan; Adam M Boruchov; Gregory Chittick; Herve Momméja-Marin; Ilya G Glezerman
Journal:  Am J Kidney Dis       Date:  2015-01-17       Impact factor: 8.860

6.  Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups.

Authors:  B Sis; M Mengel; M Haas; R B Colvin; P F Halloran; L C Racusen; K Solez; W M Baldwin; E R Bracamonte; V Broecker; F Cosio; A J Demetris; C Drachenberg; G Einecke; J Gloor; D Glotz; E Kraus; C Legendre; H Liapis; R B Mannon; B J Nankivell; V Nickeleit; J C Papadimitriou; P Randhawa; H Regele; K Renaudin; E R Rodriguez; D Seron; S Seshan; M Suthanthiran; B A Wasowska; A Zachary; A Zeevi
Journal:  Am J Transplant       Date:  2010-01-29       Impact factor: 8.086

7.  Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy.

Authors:  Christopher K Buehrig; Donna J Lager; Mark D Stegall; Michelle A Kreps; Walter K Kremers; James M Gloor; Thomas R Schwab; Jorge A Velosa; Mary E Fidler; Timothy S Larson; Matthew D Griffin
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

8.  Treatment of renal allograft polyoma BK virus infection with leflunomide.

Authors:  Michelle A Josephson; Daniel Gillen; Basit Javaid; Pradeep Kadambi; Shane Meehan; Preston Foster; Robert Harland; Richard J Thistlethwaite; Marc Garfinkel; Walter Atwood; Joslynn Jordan; Molly Sadhu; Michael J Millis; James Williams
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

9.  Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection.

Authors:  S Teschner; P Gerke; M Geyer; J Wilpert; B Krumme; T Benzing; G Walz
Journal:  Transplant Proc       Date:  2009 Jul-Aug       Impact factor: 1.066

10.  A novel treatment regimen for BK viremia.

Authors:  Rumina A Zaman; Robert B Ettenger; Hay Cheam; Mohammed H Malekzadeh; Eileen W Tsai
Journal:  Transplantation       Date:  2014-06-15       Impact factor: 4.939

View more
  1 in total

1.  Native kidney BK virus nephropathy, a systematic review.

Authors:  Ankur Shah; Vinayak Kumar; Matthew B Palmer; Jennifer Trofe-Clark; Benjamin Laskin; Deirdre Sawinski; Jonathan J Hogan
Journal:  Transpl Infect Dis       Date:  2019-05-11       Impact factor: 2.228

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.